Abstract:Background: The establishment of the gut microbiome plays a key symbiotic role in the developing immune system; however, its influence on vaccine response is yet uncertain. We prospectively investigated the composition and diversity of the early-life gut microbiome in relation to infant antibody response to two routinely administered vaccines. Methods: Eighty-three infants enrolled in the New Hampshire Birth Cohort Study were included in the analysis. We collected blood samples at 12 months of age and assayed the isolated serum to quantify total IgG and measured antibody to pneumococcal capsular polysaccharide and tetanus toxoid. Stool samples were collected from infants at 6 weeks of age and sequenced using 16S rRNA, and a subset of 61 samples were sequenced using shotgun metagenomics sequencing. Results: We observed differences in beta diversity for 16S 6-week stool microbiota and pneumococcal and tetanus IgG antibody responses. Metagenomics analyses identified species and metabolic pathways in 6-week stool associated with tetanus antibody response, in particular, negative associations with the relative abundance of Aeriscardovia aeriphila species and positive associations with the relative abundance of species associated with CDP-diacylglycerol biosynthesis pathways. Conclusions: The early gut microbiome composition may influence an infant's vaccine response. Impact: Early intestinal microbiome acquisition plays a critical role in immune maturation and in both adaptive and innate immune response in infancy. We identified associations between early life microbiome composition and response to two routinely administered vaccines-pneumococcal capsular polysaccharide and tetanus toxoid-measured at approximately 1 year of age. Our findings highlight the potential impact of the gut microbiome on infant immune response that may open up opportunities for future interventions.

Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms

The Impact of Gut Microbiota on Vaccine Immune Efficacy and Potential Mechanisms

Innate Immune Memory Of Tissue-Resident Macrophages And Trained Innate Immunity: Re-Vamping Vaccine Concept And Strategies

Probiotics, antibiotics and the immune responses to vaccines

Aging and Microbiome in the Modulation of Vaccine Efficacy

Recent five-year progress in the impact of gut microbiota on vaccination and possible mechanisms

The Mammalian Intestinal Microbiome: Composition, Interaction with the Immune System, Significance for Vaccine Efficacy, and Potential for Disease Therapy

Microbiome-based interventions to modulate gut ecology and the immune system

Intestinal Microbiota and Its Effect on Vaccine-Induced Immune Amplification and Tolerance

Mechanisms of microbiota modulation: Implications for health, disease, and therapeutic interventions

Immunomodulation by commensal and probiotic bacteria

Is the oral microbiome a source to enhance mucosal immunity against infectious diseases?

Microbiome-Immune Dynamics: Insights into Infectious Diseases

A prospective study of the infant gut microbiome in relation to vaccine response

Systemic instruction of cell-mediated immunity by the intestinal microbiome

A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines

Interaction between microbiota and immunity in health and disease

Vaccine-induced time- and age-dependent mucosal immunity to gastrointestinal parasite infection

Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity

The gut microbiota modifies antibody durability and booster responses after SARS-CoV-2 vaccination

The aging gut microbiome and its impact on host immunity